(Q40644646)

English

Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes

scientific article published on June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

author name string

Kiyoe Ohta

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sadako Kuno

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ikuko Mizuta

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Aya Fujinami

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Hidehito Matsui

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Mitsuhiro Ohta

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

617-626

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Differential effects of three dopamine receptor agonists in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Regulation of nerve growth factor synthesis/secretion by catecholamine in cultured mouse astroglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Catecholamines increase nerve growth factor mRNA content in both mouse astroglial cells and fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

A rapid microfluorimetric determination of monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Neurotrophic factors: from molecule to man.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Astroglial neurotrophic and neurite-promoting factors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Genetically modified PC12 brain grafts: survivability and inducible nerve growth factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Microencapsulated bovine chromaffin cells in vitro: effect of density and coseeding with a NGF-releasing cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

Behavioral involvement of central dopamine D1 and D2 receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900321-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0024-3205(03)00321-7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

release_avcztbamwvgqvcvuiyrtw4i4su

1 reference

https://api.fatcat.wiki/v0/release/avcztbamwvgqvcvuiyrtw4i4su

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40644646&oldid=1904093659"